Liberman U A, Eil C, Marx S J
J Clin Invest. 1983 Feb;71(2):192-200. doi: 10.1172/jci110759.
We evaluated the interaction of [3H]1,25(OH)2D3 with skin fibroblasts cultured from normal subjects or from affected members of six kindreds with rickets and resistance to 1-alpha, 25(OH)2D [1,25(OH)2D]. We analyzed two aspects of the radioligand interaction; nuclear uptake with dispersed, intact cells at 37 degrees C and binding at 0 degrees C with soluble extract ("cytosol") prepared from cells disrupted in buffer containing 300 mM KCl and 10 mM sodium molybdate. With normal fibroblasts the affinity and capacity of nuclear uptake of [3H]1,25(OH)2D3 were 0.5 nM and 10,300 sites per cell, respectively; for binding with cytosol these were 0.13 nM and 8,900 sites per cell, respectively. The following four patterns of interaction with [3H]1,25(OH)2D3 were observed with cells cultured from affected patients: (a) two kindreds; cytosol binding and whole-cell nuclear uptake both unmeasurable; (b) one kindred, decreased capacity and normal affinity both for binding in cytosol and for nuclear uptake in whole cells; (c) two kindreds, normal or nearly normal capacity and affinity of binding in cytosol but unmeasurable whole-cell nuclear uptake; and (d) one kindred, normal capacity and affinity of both cytosol binding and whole-cell nuclear uptake. In all cases where the radioligand bound with high affinity in nucleus or cytosol, the nucleus- or cytosol-associated radioligand exhibited normal sedimentation velocity on sucrose density gradients. When two kindreds exhibited similar patterns (i.e. pattern a or c) with the analyses of cultured fibroblasts, clinical features in affected members suggested that the underlying genetic defects were not identical.
(a) Fibroblasts cultured from human skin manifest nuclear uptake and cytosol binding of [3H]1,25(OH)2D3 that is an expression of the genes determining these processes in target tissues. (b) Based upon data from clinical evaluations and from analyses of cultured fibroblasts, severe resistance to 1,25(OH)2D resulted from five or six distinct genetic mutations in six kindreds.
我们评估了[3H]1,25(OH)2D3与从正常受试者或六个患有佝偻病且对1-α,25(OH)2D[1,25(OH)2D]有抵抗性的家族的患病成员培养的皮肤成纤维细胞的相互作用。我们分析了放射性配体相互作用的两个方面:37℃下分散的完整细胞的核摄取以及在0℃下与从在含有300mM氯化钾和10mM钼酸钠的缓冲液中破碎的细胞制备的可溶性提取物(“胞质溶胶”)的结合。对于正常成纤维细胞,[3H]1,25(OH)2D3的核摄取亲和力和容量分别为0.5nM和每个细胞10300个位点;对于与胞质溶胶的结合,这些分别为0.13nM和每个细胞8900个位点。在用患病患者培养的细胞中观察到以下四种与[3H]1,25(OH)2D3的相互作用模式:(a)两个家族;胞质溶胶结合和全细胞核摄取均无法测量;(b)一个家族,胞质溶胶结合和全细胞核摄取的容量降低而亲和力正常;(c)两个家族,胞质溶胶结合的容量和亲和力正常或接近正常,但全细胞核摄取无法测量;以及(d)一个家族,胞质溶胶结合和全细胞核摄取的容量和亲和力均正常。在放射性配体在细胞核或胞质溶胶中以高亲和力结合的所有情况下,与细胞核或胞质溶胶相关的放射性配体在蔗糖密度梯度上表现出正常的沉降速度。当两个家族在培养的成纤维细胞分析中表现出相似模式(即模式a或c)时,患病成员的临床特征表明潜在的遗传缺陷并不相同。
(a)从人皮肤培养的成纤维细胞表现出[3H]1,25(OH)2D3的核摄取和胞质溶胶结合,这是靶组织中决定这些过程的基因的一种表达。(b)根据临床评估和培养的成纤维细胞分析的数据,六个家族中严重的1,25(OH)2D抵抗是由五或六个不同的基因突变引起的。